Therapy Management Using Modified 2-Weeks-On/1-Week-Off Dosing Schedule in Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario

This patient case is fictional and does not represent events or a response from an actual patient. The authors developed this fictional case for educational purposes only. Brady, a 54-year-old white male, was diagnosed with metastatic renal cell carcinoma (mRCC). Two and a half years prior, he had u...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Adv Pract Oncol
Autors principals: Allman, Kimberly D., Ryan, Joanne C., Clair, Andrew, Yenser-Wood, Sarah
Format: Artigo
Idioma:Inglês
Publicat: Harborside Press LLC 2019
Matèries:
Grand Rounds
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7779571/
https://ncbi.nlm.nih.gov/pubmed/33457061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2019.10.5.6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars